Amyloid-beta induces chemokine secretion and monocyte migration across a human blood--brain barrier model.
Milan Fiala(University of California, Los Angeles), Alex E. Roher(Barrow Neurological Institute), Barbara Sherry(Feinstein Institute for Medical Research), Yu‐Min Kuo(National Yang Ming Chiao Tung University), Marlys H. Witte(University of Arizona), Diane Lorton(Banner Sun Health Research Institute), Ling Zhang(Guizhou University), Xiao-Hu Gan(University of California, Los Angeles), Dennis Way(University of Arizona), Dennis D. Taub(National Institute on Aging), Suzan Hama(University of California, Los Angeles), Michael C. Graves(University of California, Los Angeles), Martin Weinand(University of Arizona)
PubMed
July 1, 1998
Cited by 231
Related Papers
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
|American Journal Of Pathology|1999|1.5k
Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease.
|Journal of Biological Chemistry|1993|799
beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease.
|Proceedings of the National Academy of Sciences|1993|742
Cerebral Amyloid Angiopathy
|American Journal Of Pathology|1998|682